• About Us
  • Contact
FNN
  • News Categories
    • Company News
    • Interviews
    • Market Reports
    • Stock Watch
    • Company Presentations
    • Funds Management
  • Funds Management
    • Acorn Capital
      • Acorn Capital Investment Fund
    • Altrinsic
      • Altrinsic Global Advisors
    • Antares
      • Antares Australian Equities Fund
      • Antares Dividend Builder
      • Antares Elite Opportunities Fund
      • Antares Fixed Income Fund
      • Antares Listed Property Fund
    • Ausbil
      • Ausbil 130/30 Focus Fund
      • Ausbil Active Sustainable Equity Fund
      • Ausbil Australian Active Equity Fund
      • Ausbil Australian Emerging Leaders Fund
      • Ausbil MicroCap Fund
    • Capital Property Funds
      • Capital Property Funds
    • Fairview
      • Fairview Equity Partners Emerging Companies
    • Hunter Hall
      • Hunter Hall Global Value
    • Intermede
      • Intermede Global Equities Fund
    • MLC
      • MLC Inflation Plus
    • Presima
      • Presima Global Property Securities Concentrated Fund
    • ResiFund
      • ResiFund
    • Ruffer
      • Ruffer
    • Russell Investments
      • Russell Investments
    • Tribeca Investment Partners
      • Tribeca Investment Partners
    • VanEck
      • VanEck
  • Expert Insights
    • Martin Crabb
    • Jeffrey Liu
    • Michael Gable
    • Patrick Taylor
  • Media Releases
  • Investor Events
    • FNN Events

Media Releases › SUDA Pharmaceuticals

View All SUDA Pharmaceuticals News


SUDA Pharmaceuticals - Change of Director's Interest Notice - Michael Baker

16 Feb 2021 04:40 PM


To view the Change of Director’s Interest Notice, download the attached PDF.

 Download this document

Subscribe

Subscribe for our daily email digest

Company Directors

  • Dr Michael Baker (CEO)
  • Mr Joseph Ohayon (CFO)
  • Mr Paul Hopper (Executive Chairman)
  • Mr David Phillips (Executive Director)
  • Mr David Simmonds (Non-Executive Director)

Contact Information

  • (08) 6142 5555
  • http://www.sudaltd.com.au
  • Level 1, Unit 12, 55 Howe Street, OSBORNE PARK, WA, Australia, 6017

Latest Company News

Stocks of the Hour: SKY, BetMakers & Costa Group

13 minutes ago

NeuroScientific Biopharmaceuticals (ASX:NSB) targeting Alzheimer's and multiple sclerosis

40 minutes ago

Respiri (ASX:RSH) to sell wheezo over Sigma network

An hour ago

Novonix (ASX:NVX) to expand anode manufacturing capability

2 hours ago

Wide Open Agriculture (ASX:WOA) to sell dairy-free milk into NSW and Vic

3 hours ago

ikeGPS Group (ASX:IKE) announces $1.2m contract extension

4 hours ago

Latest Media Releases

Centuria Capital Group - Market Update

6 hours ago

SUDA Pharmaceuticals Placement Raises $3.65m

Yesterday

SUDA Pharmaceuticals - Proposed issue of securities

Yesterday

SUDA Pharmaceuticals - Disclosure Document Prospectus $3.65m

Yesterday

Centuria Industrial REIT - Dividend/Distribution

2 days ago

Centuria Industrial REIT - June 2021 Distribution Declaration

2 days ago

Centuria Office REIT - June 2021 Distribution Declaration

2 days ago

Centuria Office REIT - Dividend/Distribution

2 days ago

Sequoia Financial Group - Change in substantial holding

2 days ago

Immutep - Proposed issue of securities

2 days ago

Recent Insights

Growth Focus: New Century Resources Ltd (NCZ)

13/05/2021 13:54

Growth Focus: Wagners Holding Company Limited (WGN)

30/04/2021 15:55

Growth Focus: Select Harvest Limited (SHV)

08/04/2021 11:36

Growth Focus: Kathmandu Holdings Limited (KMD)

26/03/2021 14:33

Growth Focus: Qantas Airways Ltd (QAN)

12/03/2021 12:06

FNN

ABN 31 117 966 328
Disclaimer
Privacy Policy

Categories

  • Company News
  • Market Reports
  • Interviews
  • Presentations
  • Funds Management

Newsletter

Receive Daily News to your email

Recent Companies

  • ASX:ADH
  • ASX:ALU
  • ASX:WOW
  • ASX:AMP
  • ASX:ANZ
  • ASX:WBC
  • ASX:IPL
  • ASX:APT
  • ASX:BHP
  • ASX:XRO
  • ASX:RIO
  • ASX:z1P
  • ASX:ASB
  • ASX:BET
  • ASX:BLD
  • ASX:BOQ
  • ASX:CBA
  • ASX:BLG
  • ASX:BOQ
  • ASX:BUB
  • ASX:CBA
  • ASX:CE1
  • ASX:CGC
  • ASX:CGF
  • ASX:CIP
  • ASX:CNI
  • ASX:BKW
  • ASX:COL
  • ASX:CSL
  • ASX:CWN
  • ASX:NXL
  • ASX:SEQ
  • ASX:AXE
  • ASX:DMP
  • ASX:DXS
  • ASX:EOS
  • ASX:GNC
  • ASX:UMG
  • ASX:NUF
  • ASX:IAG
  • ASX:IKE
  • ASX:IMM
  • ASX:IRE
  • ASX:JHX
  • ASX:Z1P
  • ASX:WSP
  • ASX:LBY
  • ASX:MCL
  • ASX:MLT
  • ASX:SOL

Copyright Finance TV Pty Ltd All Rights Reserved

  • Home
  • News Categories
    • Company News
    • Interviews
    • Market Reports
    • Stock Watch
    • Company Presentations
    • Funds Management
  • Funds Management
    • Acorn Capital
      • Acorn Capital Investment Fund
    • Altrinsic
      • Altrinsic Global Advisors
    • Antares
      • Antares Australian Equities Fund
      • Antares Dividend Builder
      • Antares Elite Opportunities Fund
      • Antares Fixed Income Fund
      • Antares Listed Property Fund
    • Ausbil
      • Ausbil 130/30 Focus Fund
      • Ausbil Active Sustainable Equity Fund
      • Ausbil Australian Active Equity Fund
      • Ausbil Australian Emerging Leaders Fund
      • Ausbil MicroCap Fund
    • Capital Property Funds
      • Capital Property Funds
    • Fairview
      • Fairview Equity Partners Emerging Companies
    • Hunter Hall
      • Hunter Hall Global Value
    • Intermede
      • Intermede Global Equities Fund
    • MLC
      • MLC Inflation Plus
    • Presima
      • Presima Global Property Securities Concentrated Fund
    • ResiFund
    • Ruffer
    • Russell Investments
    • Tribeca Investment Partners
    • VanEck
  • Expert Insights
    • Martin Crabb
    • Jeffrey Liu
    • Michael Gable
    • Patrick Taylor
  • Media Releases
  • Investor Events
    • FNN Events